Radiation therapy for cerebral metastases: Non-stereotactic treatment options.

Timothy J Harris, John G Roubil

Journal: Advances in cancer research 2025;165():231-254

PMID: 40518191

Abstract

Human development of the blood-brain-barrier - a semi-permeable membrane that both separates and protects the brain and spinal cord from potential toxins coursing through the human circulatory system, while simultaneously permitting oxygen and nutrient delivery - also lead to the creation of the largest sanctuary site for malignancy in the human body: the central nervous system (CNS) . The most commonly used cocktails of chemotherapeutic treatments are unable to breach the blood-brain-barrier and treat metastatic cancer cells seeking asylum behind its walls, and other sanctuary sites (e.g. genital tract, testicles, placenta and umbilical cord in pregnancy, etc.). As a result, therapies that are unobstructed by the blood-brain-barrier are of paramount importance when treating CNS metastases. Radiation therapy (RT) is among these commonly employed modalities and can be used as both a first line treatment and, in some cases, as prophylaxis against microscopic disease armed with the potential to mature into symptomatic cerebral metastases.

Copyright © 2025. Published by Elsevier Inc.

Address: Department of Radiation Oncology, Massey Comprehensive Cancer Center, Virginia Commonwealth University (VCU) Health System, Richmond, VA, United States.; Department of Radiation Oncology, Massey Comprehensive Cancer Center, Virginia Commonwealth University (VCU) Health System, Richmond, VA, United States. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.